Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - estriol, quantity: 1 mg - tablet, uncoated - excipient ingredients: amylopectin; potato starch; lactose monohydrate; magnesium stearate - short-term treatment of menopausal syndrome. review the need for continuation of treatment after 6 months treatment, taking into account the risk-benefit ratio for the individual user at that moment (including cardiovascular disease and breast cancer, refer to clinical trials and precautions). ovestin tablets should only be continued for as long as the benefit outweighs the risks.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 0.5mg;   - pessary - 0.5 mg - active: estriol 0.5mg   excipient: hard fat - atrophy of the lower urogenital tract related to oestrogen deficiency, notably · for the treatment of vaginal complaints such as dyspareunia, dryness and itching · for the prevention of recurrent infections of the vagina and the lower urinary tract · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and postoperative therapy in postmenopausal women undergoing vaginal surgery. a diagnostic aid in case of a doubtful atrophic cervical smear.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 2mg;   - tablet - 2 mg - active: estriol 2mg   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate potato starch povidone - atrophy of the lower urogenital tract related to oestrogen deficiency, notably · for the treatment of vaginal complaints such as dyspareunia, dryness and itching · for the prevention of recurrent infections of the vagina and the lower urinary tract · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and postoperative therapy in postmenopausal women undergoing vaginal surgery. climacteric complaints such as hot flushes and night sweating. a diagnostic aid in case of a doubtful atropic cervical smear. infertility due to cervical hostility.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 0.1%{relative};   - vaginal cream - 0.1 % - active: estriol 0.1%{relative}   excipient: cetyl alcohol chlorhexidine hydrochloride glycerol lactic acid octyldodecanol polysorbate 60 purified water sodium hydroxide sorbitan stearate spermaceti stearyl alcohol - atrophy of the lower urogenital tract related to oestrogen deficiency, notably: · for the treatment of vaginal complaints such as dyspareunia, dryness and itching. · for the prevention of recurrent infections of the vagina and lower urinary tract. · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and post-operative therapy in postmenopausal women undergoing vaginal surgery. a diagnostic aid in case of a doubtful atrophic cervical smear.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - estriol - vaginal cream - 1mg/1gram

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - estriol, quantity: 0.5 mg - pessary, moulded - excipient ingredients: hard fat; cetomacrogol 1000; glyceryl ricinoleate - vulvo-vaginal complaints due to oestrogen deficiency associated with the climacteric and the postmenopause or after ovariectomy - atrophic vaginitis; - pruritus vulvae; - dyspareunia due to vulvo-vaginal atrophy; - as auxillary therapy in the treatment of vaginal infections - as pre-operative therapy for vulvo-vaginal surgery and during subsequent convalescence; - ulcers in cases of prolapse of the uterus or vagina; - to avoid misinterpretation of a cytological smear.

Canada - English - Health Canada

novartis pharmaceuticals canada inc - omalizumab - powder for solution - 150mg - omalizumab 150mg - respiratory agents, miscellaneous

Canada - English - Health Canada

novartis pharmaceuticals canada inc - omalizumab - solution - 75mg - omalizumab 75mg - respiratory agents, miscellaneous

Canada - English - Health Canada

novartis pharmaceuticals canada inc - omalizumab - solution - 150mg - omalizumab 150mg - respiratory agents, miscellaneous

Canada - English - Health Canada

jubilant draximage inc. dba jubilant radiopharma - rubidium chloride rb 82 - solution - 3.7gbq - rubidium chloride rb 82 3.7gbq